AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Clinical trial NCT05628636 · COMPLETED

Trial details

NCT number: NCT05628636
Sponsor: Cerecin
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2022-11-14
Primary completion: 2022-12-22
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.